Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,500 shares at $42.50 ($64K) on 2017-02-03, disclosed to the SEC on 2017-02-06.
Open-market sale of $64k NBIX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2017-11-06 | $7.4M | — | Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |